• Sign In
  • Register
  • Glossary
  • Share/Bookmark
  • RSS
All About Bleeding

Factor X

This Global website is not intended to represent or suggest that particular products are approved or authorized in any particular jurisdiction. You should not construe anything on this website as a promotion or solicitation for any product or service, or as suggesting that a product or service be used where it is not approved or authorized by applicable law and regulation in a particular country, territory, or jurisdiction. To learn which products are approved or authorized in particular countries, please consult the appropriate country-specific website.

Factor Products

Coagulation therapy is the foundation of CSL Behring’s broad range of therapies.

Learn More

Indications

Factor X replacement therapy is indicated for the correction of factor X deficiency.

Until recently, factor X deficiency was treated with fresh frozen plasma (FFP) or a prothrombin complex concentrate (PCC), both of which contain factor X.27 FFP as a means of a correcting a factor X deficiency is rather limited because of low and unpredictable concentrations of vitamin K-dependent factors.4-5 28 A recently developed factor X concentrate (Factor X P Behring) contains 100 – 200 IU of Factor X as well as 100 IU of factor IX (actual factor X content is included on the product label).27

Registration status and indications vary from country to country. Please contact your local CSL Behring representative and review the respective prescribing information before considering using a Factor X therapy.

Last Updated: 3/15/2013 10:26 AM
  • E-mail
  • Print
  • Share